Aptar Reports Second Quarter 2023 Results
Second Quarter 2023 Highlights *Reported sales increased 6% and net income increased 31% to $83 million *Core sales increased 4% and adjusted EBITDA of $181 million increased 13% from the prior year *Pharma proprietary drug delivery systems grew across the majority of end-use categories *Beauty’s fragrance dispensing technologies had double-digit growth in the quarter *Issued new Corporate Sustainability Report highlighting ESG commitments and initiatives